ArticleThe Journal of allergy and clinical immunology2023
C1 inhibitor and prolylcarboxypeptidase modulate prekallikrein activation on endothelial cells.
Alona A Merkulova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it